Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From OncoResponse Inc
Emerging Company Profile: Harvesting blood and tissue samples from patients treated with PD-1 immunotherapy, OncoResponse is developing antibodies it believes can transform cold solid tumors into hot.
Private Company Edition: The astonishing pace of venture capital investment in drug development continues with another $1.5bn in financings of $100m or more, including $152m for Pyxis and $126m for Omega. New VC funds also continue to launch, including RiverVest’s fifth fund, totaling $275m.
- Large Molecule
- Other Names / Subsidiaries
- Paganini Biopharma